Americafirst Capital Management LLC bought a new position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 7,491 shares of the pharmacy operator’s stock, valued at approximately $578,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of WBA. Franklin Resources Inc. increased its position in shares of Walgreens Boots Alliance by 24.7% during the second quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock worth $1,448,939,000 after purchasing an additional 3,662,302 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in Walgreens Boots Alliance by 471.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock valued at $258,077,000 after acquiring an additional 2,718,800 shares during the period. Vanguard Group Inc. increased its position in Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after acquiring an additional 1,926,108 shares during the period. Glenview Capital Management LLC acquired a new position in Walgreens Boots Alliance in the 2nd quarter valued at about $136,875,000. Finally, Harding Loevner LP increased its position in Walgreens Boots Alliance by 85.3% in the 3rd quarter. Harding Loevner LP now owns 2,844,207 shares of the pharmacy operator’s stock valued at $115,725,000 after acquiring an additional 1,309,179 shares during the period. Institutional investors and hedge funds own 61.18% of the company’s stock.

In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, October 26th. The stock was bought at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is owned by insiders.

Shares of Walgreens Boots Alliance Inc (WBA) opened at $76.07 on Monday. The company has a market capitalization of $75,340.00, a P/E ratio of 21.01, a PEG ratio of 1.29 and a beta of 1.22. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. Walgreens Boots Alliance Inc has a 52 week low of $63.82 and a 52 week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The business had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The company’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.10 EPS. research analysts expect that Walgreens Boots Alliance Inc will post 5.7 earnings per share for the current fiscal year.

Walgreens Boots Alliance announced that its board has initiated a share repurchase plan on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company’s board believes its shares are undervalued.

A number of brokerages have weighed in on WBA. Pivotal Research lowered their price objective on Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating on the stock in a report on Tuesday, October 24th. Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, October 12th. Deutsche Bank began coverage on Walgreens Boots Alliance in a report on Monday, December 4th. They issued a “hold” rating and a $78.00 price objective on the stock. Vetr raised Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Finally, Royal Bank of Canada reaffirmed a “buy” rating and issued a $88.00 price objective on shares of Walgreens Boots Alliance in a report on Wednesday, October 25th. Nine analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $86.20.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2018/01/15/7491-shares-in-walgreens-boots-alliance-inc-wba-purchased-by-americafirst-capital-management-llc.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.